LivaNova PLC (NASDAQ:LIVN) Given Average Rating of “Buy” by Analysts

Shares of LivaNova PLC (NASDAQ:LIVN) have been given a consensus recommendation of “Buy” by the seven research firms that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a hold recommendation, five have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $69.17.

Several equities research analysts recently commented on the company. Robert W. Baird boosted their target price on LivaNova from $66.00 to $72.00 and gave the stock an “outperform” rating in a report on Thursday, October 31st. Mizuho dropped their price objective on LivaNova from $80.00 to $70.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. Needham & Company LLC reaffirmed a “buy” rating and set a $75.00 target price on shares of LivaNova in a research note on Monday, November 25th. The Goldman Sachs Group assumed coverage on LivaNova in a report on Friday, October 4th. They set a “buy” rating and a $65.00 target price on the stock. Finally, Baird R W raised shares of LivaNova from a “hold” rating to a “strong-buy” rating in a report on Tuesday, September 17th.

Institutional Investors Weigh In On LivaNova

Hedge funds have recently modified their holdings of the stock. Fifth Third Bancorp increased its stake in LivaNova by 97.1% in the 2nd quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock worth $37,000 after purchasing an additional 332 shares in the last quarter. Hexagon Capital Partners LLC increased its position in shares of LivaNova by 117.8% in the second quarter. Hexagon Capital Partners LLC now owns 684 shares of the company’s stock worth $37,000 after acquiring an additional 370 shares in the last quarter. Lazard Asset Management LLC acquired a new stake in shares of LivaNova during the first quarter valued at approximately $84,000. Canada Pension Plan Investment Board purchased a new stake in shares of LivaNova in the 2nd quarter valued at approximately $88,000. Finally, Central Pacific Bank Trust Division purchased a new stake in shares of LivaNova in the 3rd quarter valued at approximately $178,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

LivaNova Stock Up 0.5 %

LIVN stock opened at $49.98 on Tuesday. The firm’s 50-day moving average is $52.14 and its two-hundred day moving average is $51.67. The company has a market capitalization of $2.71 billion, a price-to-earnings ratio of 119.00 and a beta of 0.98. LivaNova has a 52 week low of $43.15 and a 52 week high of $64.47. The company has a current ratio of 3.37, a quick ratio of 2.87 and a debt-to-equity ratio of 0.46.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.